European Journal of Medicinal Chemistry p. 1214 - 1222 (2018)
Update date:2022-08-04
Topics:
Angeli, Andrea
Trallori, Elena
Ferraroni, Marta
Di Cesare Mannelli, Lorenzo
Ghelardini, Carla
Supuran, Claudiu T.
A series of disubstituted selenazole derivatives was synthetized and evaluated as carbonic anhydrase (CA, EC 4.2.1.1) inhibitors against the human (h) isoforms hCA I, II, IV, VA, VB and IX, involved in a variety of diseases including glaucoma, retinitis pigmentosa, epilepsy, arthritis and tumors. The investigated compounds showed potent inhibition against the tumor-associated transmembrane hCA IX, with KIs in the subnanomolar – low nanomolar range, and were evaluated for their effects on cell viability against the human prostate (PC3) and breast (MDA-MB-231) cancer cell lines, showing effective anti-tumor activity. These selenazoles are interesting leads for the development of new, isoform-selective CA IX inhibitors.
View MorePengchen New Material Technology Co., Ltd.
Contact:+86-512-63680537
Address:99.6 km of national road 318, Meiyan Community,Pingwang Town, Wujiang District, Suzhou 215225
Shaanxi HuaTai Bio-fine chemical company Ltd
Contact:86-029-87862197
Address:No. 5, 3rd Floor, 29 Yanta North Road, Beilin Dist.
SHENZHEN PENGCHENG REDSTAR INDUSTRY CO.,LTD
Contact:+86-755-82412922
Address:Room 8066, East Block, Square City, Jiabin Road, Luohu District
Contact:0512-63006287
Address:no.88.YISHENG Road,etdz-WUJIANG,SUZHOU,CHINA
Shangyu Sanhechemicals Co.,LTD.
Contact:86-0571-56696839
Address:Num.2952,Nanhuan Road,Binjiang District,Hangzhou,China
Doi:10.1016/j.cplett.2005.03.127
(2005)Doi:10.1093/geront/41.6.723
(1921)Doi:10.1016/j.molcata.2013.11.032
(2014)Doi:10.1016/j.tetlet.2018.09.056
(2018)Doi:10.1055/s-2008-1072504
(2008)Doi:10.1007/s10593-006-0097-z
(2006)